Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

44 results about "Anabolism" patented technology

Anabolism (/əˈnæbəlɪsm/) is the set of metabolic pathways that construct molecules from smaller units. These reactions require energy, known also as an endergonic process. Anabolism is the building-up aspect of metabolism, whereas catabolism is the breaking-down aspect. Anabolism is usually synonymous with biosynthesis.

Ganoderma lucidum transcription factor C2H2-3, method for synthesizing ganoderic acid by using same and application of ganoderma lucidum transcription factor C2H2-3

InactiveCN119061026AIncrease the content of ganoderma acidFungiBacteriaNucleotideGenetic engineering
The invention belongs to the technical field of molecular biology and genetic engineering, and particularly relates to a ganoderma lucidum transcription factor C2H2-3, a method for synthesizing ganoderic acid by using the ganoderma lucidum transcription factor C2H2-3 and application of the ganoderma lucidum transcription factor C2H2-3. The invention provides a ganoderma lucidum transcription factor C2H2-3 (an amino acid sequence is shown as SEQ ID NO.2) with a nucleotide sequence shown as SEQ ID NO.1, and further provides application of the transcription factor C2H2-3 in activation of SQS gene expression of ganoderma lucidum. The ganoderma lucidum transcription factor C2H2-3 provided by the invention is combined with a ganoderma lucidum SQS gene promoter and positively regulates and controls the expression of an SQS gene; key enzymes participating in ganoderic acid anabolism can be regulated and controlled, so that the content of ganoderic acid in lucid ganoderma is regulated and controlled.
Owner:ZHEJIANG SHOUXIANGU PHARMA CO LTD +2

Inc.3024.2-GbMYB2 for regulating and controlling synthesis of gingko flavonoids and application of lnc.3024.2-GbMYB2

The invention discloses lnc.3024.2-GbMYB2 for regulating and controlling synthesis of gingko flavonoids and application of the lnc.3024.2-GbMYB2, and belongs to the technical field of genetic engineering, aiming at analyzing the biological functions of lncRNA (lnc.3024.2) and MYB target gene (Gb06719) participating in gingko flavonoids anabolism, by utilizing the technical means of bioinformatics analysis, real-time fluorescence quantification, subcellular localization, prokaryotic expression, genetic transformation and the like, the GbMYB2 can be used for regulating and controlling synthesis of the gingko flavonoids. The regulation mechanism of the transcription factor lnc.3024.2 and the target gene GbMYB2 of the lnc.3024.2 participating in the synthesis of the flavonoids in the ginkgo leaves is discussed. And a gene regulation network model of gingko flavonoid anabolism is further enriched. On the basis, the molecular mechanism of regulating and controlling the synthesis of the gingko flavonoids by the lncRNA targeting MYB is further analyzed on the early-stage basis, the content of the gingko flavonoids is increased by utilizing a genetic engineering technical means, and a new way is provided for researching the synthesis way of the gingko flavonoids.
Owner:YANGTZE UNIVERSITY

Application of Aldometanib in preparation of medicine for preventing and treating immune-related adverse reactions and diseases

The invention provides an application of a compound Aldometanib in preparation of a medicine for preventing and treating immune-related adverse reactions and diseases. Based on the first discovered prevention and treatment effects of Aldometanib on fatal immune hepatitis, immune myocarditis, pneumonia and enteritis, the invention specifically discloses application of Aldometanib in preparation of drugs for prevention and treatment of immune-related adverse reactions and diseases, and the main mechanism is that Aldometanib activates immune cells AMPK, enhances catabolism of immune cells, promotes immune cell apoptosis, promotes immune cell apoptosis, and improves immune cell apoptosis. The anabolism of the immune cells is inhibited, so that the expression of effector factors of the immune cells is controlled, and inflammatory factor storm is inhibited. Aldometanib has the effects of preventing the occurrence of immune-related adverse reactions and diseases, and inhibiting the attack levels of the immune-related adverse reactions and diseases, so that non-lethal and lethal injuries caused by an immune system to body organs are reduced.
Owner:FUJIAN CANCER HOSPITAL (FUJIAN CANCER INST FUJIAN CANCER PREVENTION & CONTROL CENT)

Lactobacillus crispatus for relieving senescence by promoting collagen synthesis and metagen of lactobacillus crispatus

The invention discloses lactobacillus crispatus for relieving senescence by promoting collagen synthesis and a metagen of the lactobacillus crispatus, and belongs to the technical field of microorganisms and medicines. The lactobacillus crispatus CCFM1462 metagen provided by the invention has a good skin anti-aging effect, the content of collagen is increased, meanwhile, the skin moisture can be increased, and the skin oxidation resistance can be improved. Specifically, the enzyme activity of MMP-3 and MMP-1 of HSF cells can be inhibited in vitro by thallus lysate, and the content of COL I and COL III and the enzyme activity of LH1 can be improved in vitro from fermentation of supernate; the enzyme activity of MMP-1 and MMP-3 can be inhibited by orally taking inactivated thalli; the self-fermented supernate is orally taken, so that the enzyme activity of LH1 and LOX can be improved, the enzyme activity of MMP-3 can be reduced, and the anabolism of collagen can be regulated and controlled.
Owner:JIANGNAN UNIV

Lysogenic bacteriophage community as well as extraction method and application thereof

According to the lysogenic phage community and the extraction method and application thereof, bacterial and phage communities are separated from in-situ soil in a medium proportion through a tangential flow technology, single bacterial communities and single phage communities are obtained through enrichment and concentration, meanwhile, mitomycin C is added into the single bacterial communities for lysogenic induction, and the lysogenic phage communities are obtained. And then filtering and enriching by using the tangential flow system to obtain a high-flux lysogenic phage community, and finally obtaining a single bacterial community, a bacterial-phage mixed community and a bacterial-lysogenic phage mixed community. The phage transplantation technology can promote indigenous microorganisms to participate in the plant growth and development process, and the transplanted lysogenous phage can participate in host plant hormone anabolism by optimizing a microbial network structure and injecting auxiliary metabolism genes. The method provides a long-acting environment-friendly microorganism synergistic growth promoting technology for green agriculture development in China.
Owner:NANJING AGRICULTURAL UNIVERSITY

Type II hyaluronic acid synthetase mutant and construction method thereof

The invention discloses a type II hyaluronic acid synthetase mutant and a construction method thereof, and belongs to the technical field of gene engineering. The catalytic activity of the hyaluronic acid synthetase derived from pasteurella multocida is improved through a protein modification method based on semi-rational design of molecular dynamics simulation, the yield of hyaluronic acid can be increased by converting the hyaluronic acid synthetase into escherichia coli or corynebacterium glutamicum, and meanwhile, the molecular weight is remarkably increased. Coevolution of HA yield and molecular weight is realized for the first time, anabolism pathways of HA are respectively constructed in escherichia coli and corynebacterium glutamicum, and the method has a good industrial application prospect.
Owner:CHANGZHOU INST OF MATERIA MEDICA

Application of aloe polysaccharide in regulation and control of energy metabolism of mitochondria

The invention discloses application of aloe polysaccharide in regulation and control of mitochondrial energy metabolism, and belongs to the field of new application of aloe polysaccharide. The aloe polysaccharide can regulate mitochondrial energy metabolism to be converted into anabolism, promote the content of protein and amino acid in cells and promote wound healing. The preparation method of the aloe polysaccharide comprises the following steps: removing two ends of fresh aloe barbadensis leaves, and soaking the fresh aloe barbadensis leaves with pure water for 1-2 days; washing with water and removing skin to obtain aloe gel to be ground; shearing the aloe vera gel to be ground in an automatic gel grinding device to finish gel grinding, so as to obtain aloe polysaccharide feed liquid; and putting the aloe polysaccharide feed liquid into a stirring tank, stirring at 4-15 DEG C, carrying out light treatment for at least 24 hours, and then collecting the aloe polysaccharide pervaporation membrane on the surface of the liquid in a high-temperature membrane forming tank at 75-95 DEG C, thereby obtaining the aloe polysaccharide pervaporation membrane.
Owner:广州市东源药业科技有限公司 +1

Method for efficiently synthesizing L-alanine by coordinating metabolic pathway of escherichia coli

The invention discloses a method for efficiently synthesizing L-alanine by coordinating metabolic pathways of escherichia coli, and belongs to the field of bioengineering. An acetic acid anabolism pathway is deleted; the pyruvic acid induction glucose metabolism regulation and control system is used for regulating and controlling L-alanine synthesis of escherichia coli, and glucose overspeed metabolism is effectively relieved; the synthesis amount of the L-alanine is increased by weakening tricarboxylic acid circulation, and the yield of the L-alanine in a 5L fermentation tank can reach 195.2 g / L. The method provided by the invention is beneficial to reducing the cost and promoting large-scale fermentation production of L-alanine, and has a very good industrial application prospect.
Owner:JIANGNAN UNIV

Sewage electrochemical coupling microbiological treatment method and device

The invention discloses a sewage electrochemical coupling microbiological treatment method and device, and belongs to the technical field of sewage treatment. Sewage is pumped into an anaerobic zone, and the sludge reflux ratio is adjusted in time by calculating the internal carbon source conversion rate, the assimilation ammonia nitrogen removal contribution rate and the like; effluent overflows to a first anoxic zone and a second anoxic zone for phosphorus and nitrogen removal through denitrification; effluent enters the aerobic zone and the micro-aerobic zone, and trace nitrogen and phosphorus are reduced under the action of electrochemical reaction and microorganisms; effluent enters a settling zone, and mud-water separation is carried out. The microbiological treatment device comprises an anaerobic zone, a first anoxic zone, a second anoxic zone, an aerobic zone, a micro-aerobic zone and a settling zone which are sequentially arranged, and the micro-aerobic zone is provided with a DO online detector 2, an electrochemical reaction device and an iron ion online detector. An electrochemical strengthening mechanism is coupled, iron ions promote metabolism of microorganisms, enrichment and directional regulation of dominant functional bacteria are achieved, the sewage treatment cost can be remarkably reduced, and the treatment efficiency can be improved.
Owner:WUHAN SHENGTAI ENVIRONMENTAL PROTECTION EQUIP MFG CO LTD

A motile injectable cell that accelerates musculoskeletal connective tissue repair

PCT designated stage expiredWO2025155768A1AntipyreticGenetically modified cellsTissue repairCXCR4
Embodiments of the present invention disclose a genetically modified cell that accelerates tissue repair by overexpressing CXCR4. This motile cell can be administered to subjects in need, enhancing tissue regeneration compared to unmodified cells. The cell may include various progenitor cell lines and demonstrates low NF-Kb pathway activity, which suppresses catabolic activity and promotes anabolism in inflammatory environments. The invention also encompasses methods of treatment using these cells, compositions containing them, and kits for their delivery.
Owner:RHODE ISLAND HOSPITAL

Application of chlorella in preparation of medicine for treating osteoarthritis

The invention discloses application of chlorella in preparation of a medicine for treating osteoarthritis, in-vivo experiments and in-vitro experiments prove that chlorella can maintain a chondrocyte metabolism steady state, inhibit expression of chondrocyte extracellular matrix catabolism-related genes and proteins, and inhibit osteoarthritis. The expression of genes and proteins related to chondrocyte extracellular matrix anabolism is promoted, and by injecting a chlorella solution into a knee joint cavity, the effects of relieving and improving OA pain are achieved; furthermore, polydopamine is used for modifying the chlorella to obtain the polydopamine-coated chlorella Ch (at) P with a photothermal effect, and the Ch (at) P not only maintains the biological activity of the chlorella, but also has the effect of delaying cartilage degeneration and OA process due to the photothermal effect under near infrared (NIR) irradiation.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Negative regulation gene ZmRPL31 for content of linoleic acid in corn kernels as well as mutant and application of negative regulation gene ZmRPL31

The invention discloses a corn kernel linoleic acid content negative regulation gene ZmRPL31 as well as a mutant and application thereof, and a candidate gene ZmRPL31 closely related to linoleic acid anabolism in a high-linoleic acid corn selfing line YM-2 is successfully screened based on BSA (Bovine Serum Albumin) population construction and RNA-seq transcriptome analysis. Corn B73 pollen is treated through an ethyl methanesulfonate mutagenesis technology, and a rpl31 homozygous mutant strain is successfully constructed. GC-MS detection is carried out on the linoleic acid content of a homozygous mutant strain, and it is confirmed for the first time that the ribosomal protein gene ZmRPL31 has a negative regulation effect on synthesis of corn linoleic acid. Wherein the linoleic acid content of the rpl31-22 homozygous mutant strain in grain tissues is remarkably increased by 43.7% compared with that of wild type corn B73, and meanwhile, the linoleic acid content of the rpl31-22 homozygous mutant strain in leaves in the seedling stage is remarkably increased by 23.5% compared with that of the wild type corn B73.
Owner:SUQIAN AGRI SCI RES INST JIANGSU ACAD OF AGRI SCI

Application of Phillyrin in the Preparation of Drugs for Treating Intervertebral Disc Degeneration

The present invention discloses the application of forsythin in the preparation of a medicament for treating intervertebral disc degeneration, belonging to the field of medical technology. In the study of intervertebral disc degeneration, it is found that forsythin can significantly inhibit the increase in catabolism and the decrease in anabolism of nucleus pulposus cells during the progression of intervertebral disc degeneration, and also has a significant inhibitory effect on the activation of the NF-κB pathway and the increase in ROS, thereby regulating the synthesis and catabolism of the extracellular matrix and cell apoptosis. Moreover, through verification, it is found that it has a therapeutic effect in a rat model of intervertebral disc degeneration, confirming that it also has a rescue effect on intervertebral disc degeneration in vivo.
Owner:SUN YAT SEN MEMORIAL HOSPITAL SUN YAT SEN UNIV

Creatine composition for improving exercise endurance and strength, and preparation method and application thereof

PendingCN122424288ABiotechnologyAnimal science
The application discloses creatine composition for improving exercise endurance and strength, and a preparation method and application thereof. The creatine composition comprises creatine, black pepper extract and oyster peptide. The scheme has the effects of significantly enhancing energy systems, promoting anabolism, inhibiting catabolism, reducing oxidative damage and accelerating recovery through the combination of components, and can be effectively used for improving exercise endurance and strength.
Owner:HUNAN QUYESH SPORTS NUTRITION PRODUCTS CO LTD

Application of MRPL41 gene / protein in the preparation of drugs for treating age-related sarcopenia

PendingCN122351433ANutritionClinical therapy
This invention belongs to the field of biomedical technology, specifically involving the application of the MRPL41 gene / protein in the preparation of drugs for treating age-related sarcopenia. This invention is the first to demonstrate that MRPL41 is a key rate-limiting factor in the assembly of mitochondrial ribosomes in aging muscle satellite cells, establishing it as a core target for the treatment of age-related sarcopenia. Overexpression of MRPL41 can promote the assembly of mitochondrial 55S holoenzymes, improve the translation efficiency of mitochondrial-encoded proteins, repair mitochondrial dysfunction at its source, thereby promoting muscle repair, improving muscle atrophy, and achieving the treatment of age-related sarcopenia. This invention provides a precise microscopic target for the treatment of age-related sarcopenia, overcoming the limitations of existing clinical therapies (such as hormone replacement and simple nutritional supplementation) due to significant side effects and "anabolism resistance," providing a new direction for the development of innovative drugs specifically for the treatment of age-related sarcopenia, and has excellent application prospects.
Owner:SUN YAT SEN UNIV +1

Genetically engineered bacterium for producing abienol as well as construction method and application of genetically engineered bacterium

The invention discloses a genetically engineered bacterium for producing abienol as well as a construction method and application thereof, and belongs to the technical field of environmental biology. In order to solve the technical problems of long fermentation period, low yield, high cost and incapability of meeting industrial production of engineering bacteria for producing abienol in the prior art, the invention provides a genetically engineered bacterium for producing abienol. A complete abienol anabolism pathway is constructed in escherichia coli, a functional membrane-free organelle system is constructed, and enzyme is collected into a membrane-free organelle through interaction of ankylopeptides, so that a metabolite channel is formed. According to the genetically engineered bacterium provided by the invention, high-yield abienol can be directly obtained from thalli, the yield of abienol is increased, the time for producing abienol by the genetically engineered bacterium is shortened, the production efficiency is improved, and the genetically engineered bacterium has a good industrial application prospect.
Owner:QINGDAO INST OF BIOENERGY & BIOPROCESS TECH CHINESE ACADEMY OF SCI +1

Nutritional compositions

The present invention relates to nutritional compositions for maintaining and enhancing one carbon (1C) metabolism. The compositions are useful for maintaining general body health, reducing physiological consequences of metabolic stress, enhancing anabolism in a growing body or in a body recovering from a disease or trauma, activating anabolic processes in the ageing body of a mammal, such as a human individual or domestic animal. The compositions comprise a combination of choline and succinate in the molar ratio 2:1.
Owner:MITOCHONDRIAL SUBSTRATE INVENTION

Promoter, threonine-producing recombinant microorganism and use thereof

Provided is a promoter, which has a nucleotide sequence shown in SEQ ID NO. 1. The promoter is obtained by means of rationally designing the promoter of a dapA gene, has obviously reduced transcriptional activity and can be used for the weakened expression of microorganism genes. Substituting the original promoters of the dapA gene, a ddh gene, an ilvA gene, a tdcB gene and a gltA gene in Corynebacterium glutamicum by using the promoter enables the expression levels of these genes to be significantly reduced, the carbon metabolic in a recombinant microorganism constructed thereby flows more to a threonine anabolism pathway, and the recombinant microorganism has a significantly improved production of threonine in comparison with an original strain and has good growth performance.
Owner:MEIHUA BIOTECH LANGFANG CO LTD

IbGH3.4b gene for coding sweet potato auxin amide synthetase and application of IbGH3.4b gene

The invention discloses an IbGH3.4b gene for encoding sweet potato auxin amide synthetase and application of the IbGH3.4b gene. The nucleotide sequence of the gene is shown as SEQ ID NO.1; the amino acid sequence of the protein is as shown in SEQ ID NO. 2; the invention also provides a related recombinant vector and a host cell. The invention further discloses application of any one of the IbGH3.4b gene for coding the sweet potato auxin amide synthetase, the protein coded by the IbGH3.4b gene, the recombinant vector and the host cell in regulation and control of plant growth and development and / or regulation and control of auxin anabolism. The acquisition of the gene for coding the sweet potato auxin amide synthetase IbGH3.4b provides a precious gene resource for molecular plant breeding, and meanwhile, the gene has important significance for analyzing the molecular mechanism of plant growth and development and auxin synthesis and metabolism. The gene can be applied to plant genetic improvement.
Owner:XUZHOU NORMAL UNIVERSITY

Application of rubimaillin in preparation of medicine for delaying intervertebral disc degeneration

The invention belongs to the technical field of biological medicines, and particularly relates to application of rubimaillin in preparation of a medicine for delaying intervertebral disc degeneration. Compared with the limitations of inexact conservative treatment effect and high surgical intervention risk in the prior art, the invention reveals for the first time that rubimaillin (MO) can effectively regulate and control a PI3K-AKT / NF-kappa B signal channel through targeted inhibition of EGFR phosphorylation, alleviates nucleus pulposus cell metabolic disorder caused by an inflammatory microenvironment from the source, significantly improves the expression of anabolism markers, and provides a new application for the treatment of the inflammatory microenvironment. The compound inhibits the release of catabolic enzymes and inflammatory factors, delays the processes of cell aging and apoptosis, and shows a clear effect of delaying the progress of IDD in animal and cellular levels. Compared with the traditional treatment, the traditional Chinese medicine composition has the advantages of good effect, low side effect and the like, so that a new way can be provided for preventing and treating the IDD.
Owner:广州医科大学附属清远医院(清远市人民医院)

Application of ZmCPK28 gene or encoding protein thereof in regulation and control of crop carbohydrate anabolism

The invention discloses an application of a ZmCPK28 gene or an encoded protein thereof in regulation and control of crop carbohydrate anabolism, and belongs to the technical field of gene engineering. By observing the phenotypes of an overexpression material and a mutant material of the ZmCPK28 gene under different nitrogen concentration conditions, the phenotype and the overground part biomass of the wild type B73-329 are superior to those of the mutant material and have no obvious difference from those of the overexpression material. Meanwhile, the ZmCPK28 gene has the function of regulating and controlling carbohydrate synthesis of corn seedlings, for example, overexpression of the ZmCPK28 gene can improve the content of sucrose and trehalose and reduce the content of glucose and fructose, and a theoretical basis is provided for clarification of the effect of ZmCPK28 in corn growth and development and sugar anabolism.
Owner:CHINA AGRI UNIV

Application of formyl phloroglucinol mixed-source terpenoid derivative or pharmaceutically acceptable salt thereof in preparation of medicine for preventing and treating liver lipid metabolism abnormality related diseases

The invention discloses application of formyl phloroglucinol mixed-source terpene derivatives or pharmaceutically acceptable salts thereof in preparation of drugs for preventing and treating liver lipid metabolism abnormality related diseases, and relates to terpenes. The liver lipid metabolism disorder related diseases are obesity, hyperlipidemia, atherosclerosis (AS), metabolism related fatty liver disease (MAFLD), non-alcoholic steatohepatitis (NASH) and type 2 diabetes mellitus (T2DM). The formyl phloroglucinol mixed-source terpenoid derivative is found to be capable of reducing anabolism of liver fatty acid and cholesterol for the first time, so that liver lipid deposition is reduced, dyslipidemia is improved, and the formyl phloroglucinol mixed-source terpenoid derivative can be used for preventing and treating liver lipid metabolism disorder related diseases.
Owner:CHINA PHARM UNIV

Screening method and application of phaffia rhodozyma strains

The invention discloses a screening method and application of phaffia rhodozyma strains. The phaffia rhodozyma strain HSASTA is obtained through screening evolution and has characteristic sequences of five key enzyme genes in the anabolism process of astaxanthin. When the phaffia rhodozyma is used for producing the astaxanthin, the yield can reach 8000 mg / kg or above. The strain can be applied to various industrial fields of health care products, food, food additives and the like, and has wide development and application prospects.
Owner:XIAMEN HUISON BIOTECH CO LTD

Eriocheir sinensis ELOVL7 gene and application thereof

PendingCN120442665AFungiBacteriaFatty acidElongase
The invention discloses an Eriocheir sinensis ELOVL7 gene and application thereof, the nucleotide sequence of the Eriocheir sinensis ELOVL7 gene is as shown in SEQ ID NO: 1, and the amino acid sequence of protein encoded by the Eriocheir sinensis ELOVL7 gene is as shown in SEQ ID NO: 2. The Eriocheir sinensis ELOVL7 gene sequence is successfully obtained through a PCR technology for the first time, the function of the ELOVL7 gene is verified through an in-vitro experiment, it is proved that the gene serves as an elongase gene to play a role in the Eriocheir sinensis fatty acid synthesis process, the function of promoting LC-PUFA synthesis is achieved, a foundation is laid for studying the LC-PUFA anabolism mechanism of the Eriocheir sinensis, and the Eriocheir sinensis ELOVL7 gene has a good application prospect. And a reference is provided for the functional research of other crustacean ELOVL7.
Owner:SHANGHAI OCEAN UNIV

Promoter, threonine-producing recombinant microorganism and use thereof

Provided is a promoter, which has a nucleotide sequence shown in SEQ ID NO. 1. The promoter is obtained by means of rationally designing the promoter of a dapA gene, has obviously reduced transcriptional activity and can be used for the weakened expression of microorganism genes. Substituting the original promoters of the dapA gene, a ddh gene, an ilvA gene, a tdcB gene and a gltA gene in corynebacterium glutamicum by using the promoter enables the expression levels of these genes to be significantly reduced, the carbon metabolic in a recombinant microorganism constructed thereby flows more to a threonine anabolism pathway, and the recombinant microorganism has a significantly improved production of threonine in comparison with an original strain and has good growth performance.
Owner:MEIHUA BIOTECH LANGFANG CO LTD

Tandem gene for biosynthesizing astaxanthin in rape seeds, expression cassette and expression method

The invention provides a tandem gene for biosynthesizing astaxanthin in rape seeds, an expression cassette and an expression method, and belongs to the technical field of gene engineering. The invention provides a tandem gene for biosynthesis of astaxanthin, and four carotenoid anabolism genes are firstly constructed into the tandem gene for a biosynthesis path of astaxanthin. The four carotenoid anabolism genes are driven based on the rape seed specific NAPIN promoter to construct an astaxanthin biosynthesis path in the rape seeds and synthesize the astaxanthin, so that the biosynthesis efficiency of the astaxanthin is improved; the expression of the astaxanthin biosynthetic gene and the accumulation of the astaxanthin in the seeds do not influence the growth, development and reproduction of the rape; in addition, fat-soluble carotenoid and astaxanthin are naturally integrated with grease in the rape seeds, and astaxanthin rapeseed oil is directly used as a product, so that the activity of astaxanthin is maintained, and the later astaxanthin extraction production cost can be reduced.
Owner:HUAZHONG NORMAL UNIV

Long-acting parathyroid hormone receptor agonist fusion protein and application thereof

The invention discloses a long-acting parathyroid hormone receptor stimulant fusion protein and application thereof. The fusion protein can inhibit the activity of RANKL and promote PTHR-mediated bone anabolism, and comprises a first arm and a second arm, the first arm comprises a functional region targeting RANKL and an Fc region, and the second arm comprises a functional region capable of activating PTHR and an Fc region. The long-acting parathyroid hormone receptor stimulant fusion protein has the advantages of better drug effect, more lasting effect, better safety, higher structural stability, higher expression quantity and the like, and the comprehensive performance of the long-acting parathyroid hormone receptor stimulant fusion protein is superior to that of the existing or potential treatment means such as teriparatide, PEG-PTH, anti-RANKL monoclonal antibody, romomonoclonal antibody or a control sample synPTH-alpha RANKL-1.
Owner:SHANGHAI BOSHENGDE BIOTECHNOLOGY CO LTD

Mannosylerythritol lipid produced by utilizing fermentation of aphid yeast XM01 strain as well as fermentation method and application of mannosylerythritol lipid

The invention discloses mannosylerythritol lipid produced by fermentation of an aphid yeast XM01 strain as well as a fermentation method and application of the mannosylerythritol lipid, and belongs to the technical field of microorganisms. The invention provides a fermentation method using the aphid torulopsis XM01 strain, through compounding and screening of a carbon source, a secondary metabolism integration pathway of sugar alcohol is effectively activated, meanwhile, synthesis of mannosylerythritol lipid MELs is effectively promoted, and the yield reaches up to 82.21 g / L; the invention further provides the MELs prepared by using the safflower oil as the first carbon source, the C10 content in a fatty acid side chain of the MELs accounts for 80% or above, and the MELs is good in emulsifying property, has antioxidant and anti-inflammatory capacities, can effectively inhibit candida albicans and promote cell proliferation, and has reference significance in application of preparing biological preparations in cosmetics and drugs by using the MELs; according to the MELs prepared by the invention, the technical problems of emulsification control and metabolic balance in the amplification process are solved by decoupling thallus growth and a product anabolism path through a time sequence.
Owner:OCEAN UNIV OF CHINA +2

Application of lactobacillus helveticus CCFM1440 in regulating and controlling anabolism of host collagen to relieve senescence

PendingCN120758408ACosmetic preparationsBacteriaBiotechnologyCollagen anabolism
The invention discloses application of lactobacillus helveticus CCFM1440 in regulating and controlling anabolism of host collagen to relieve senescence, and belongs to the technical field of microorganisms and the technical field of medicines. The metagen of the lactobacillus helveticus CCFM1440 provided by the invention has a good skin anti-aging effect, and can improve the moisture and elasticity of the skin, improve the antioxidant capacity of the skin, reduce the inflammation level of the organism and relieve aging. Specifically, the enzyme activity of LH1 and LOX of HSF cells and the content of COLIII are improved in vitro and in vitro through thallus lysate; the inactivated thalli are orally taken, so that the enzyme activity of LH1, P4H and LOX is improved, the enzyme activity of MMP-1 and MMP-3 is inhibited, and the collagen content is increased; the self-fermented supernate is orally taken, so that the enzyme activity of MMP-3 can be inhibited, the content of IL-6 and CRP can be reduced, and the skin moisture can be improved.
Owner:JIANGNAN UNIV